ST20-AS1: A Non-Coding RNA as A Potential Drug Target Or Biomarker

Target Name: ST20-AS1

NCBI ID: G283687

ST20-AS1

Other Name(s): C15orf37 | FLJ33788 | ST20 antisense RNA 1

ST20-AS1: A Non-Coding RNA as A Potential Drug Target Or Biomarker

ST20-AS1 (C15orf37), a non-coding RNA (ncRNA), has been identified as a potential drug target or biomarker for various diseases, including cancer. Its unique structure and functional characteristics make it an attractive target for researchers to investigate.

The ST20-AS1 gene, located on chromosome 15, encodes a protein with 20 unique amino acid residues. This protein is involved in various cellular processes, including cell adhesion, migration, and invasion. It plays a critical role in the development and progression of cancer, as well as in neurodegenerative diseases.

One of the key features of ST20-AS1 is its potential to interact with various proteins, including TGF-β1, a known regulator of cell growth and differentiation. This interaction between ST20-AS1 and TGF-β1 suggests that the protein may be a useful target for drugs that are effective in inhibiting the activity of TGF-β1.

In addition to its potential interactions with TGF-β1, ST20-AS1 has also been shown to interact with several other proteins, including PDGF-尾, Wnt, and Notch. These interactions highlight the protein's role in various signaling pathways that are involved in disease development and progression.

The functional relevance of ST20-AS1 is further emphasized by its expression patterns in various tissues and organs. For example, high levels of ST20-AS1 have been observed in various types of cancer, including breast, ovarian, and colorectal cancer. This suggests that targeting ST20-AS1 may be an effective way to treat these diseases.

Furthermore, the structural domain of ST20-AS1 contains several conserved secondary structure motifs, such as a long terminal fragment (LTF), a short terminal fragment (STF), and a structural domain (SD). These motifs are commonly found in proteins that play important roles in various cellular processes, including cell adhesion, migration, and invasion.

The conservation of these motifs suggests that ST20-AS1 may have similar functions in different cellular processes. Moreover, the presence of these motifs in the protein's N-terminus suggests that they may be involved in the protein's stability and/or localization in the cell.

In conclusion, ST20-AS1 is a non-coding RNA that has been identified as a potential drug target or biomarker for various diseases. Its unique structure and functional characteristics make it an attractive target for researchers to investigate. Further studies are needed to determine the exact mechanisms by which ST20-AS1 interacts with its interacting proteins and to explore its potential as a drug or biomarker.

Protein Name: ST20 Antisense RNA 1

The "ST20-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ST20-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets